Fund:

Fund clinical trials of IMMEDIATELY available promising treatments to discover new therapies.

The FUND program is designed to provide definitive answers for improving patient lives.

Promising therapies will never become part of mainstream medicine (i.e. physicians will not routinely prescribe such treatments, and insurance will not cover them) unless rigorous clinical trials prove their efficacy and define their toxicity. Therefore, GlobalCures will design, conceive and fund clinical trials for 'financial orphans' - therapies with scientific merit that lack financial profitability.


Click here to see how we prioritize trials and treatment options.


Below is a list of clinical trials on our priority list. We welcome individual donations that will allow us to research, prioritize and fund such trials.

If you are a disease specific foundation and would like to fund one of these trials or if you are a researcher and are able to conduct one of these trials, please email us at collaborations@global-cures.org


Cancer Type Trial Name

Breast Cancer

Preoperative ketorolac to prevent recurrence of breast cancer in patients with operable disease

Learn more

Lung Cancer

Preoperative ketorolac to prevent recurrence of lung cancer in patients with operable disease

Learn more

Patients as funders of discovery (FUND)

Problem

Solution

Physicians will not prescribe and insurance will not pay for promising therapies unless clinical trials prove efficacy and define toxicity.

Patients must raise funds for trials of financial orphans. GlobalCures will conceive, design, write and fund such clinical trials via the FUND program.



GlobalCures
For Patients
Location
Connect